[PDF][PDF] TP53 Mutations and Pathologic Complete Response to Neoadjuvant Cisplatin and Fluorouracil Chemotherapy in Resected Oral Cavity Squamous Cell …
F Perrone, P Bossi, B Cortelazzi, L Locati… - Journal of Clinical …, 2010 - academia.edu
F Perrone, P Bossi, B Cortelazzi, L Locati, P Quattrone, MA Pierotti, S Pilotti, L Licitra
Journal of Clinical Oncology, 2010•academia.eduTP53 Mutations and Pathologic Complete Response to Neoadjuvant Cisplatin and Fluorouracil
Chemotherapy in Resected Oral Cavity S Page 1 TP53 Mutations and Pathologic Complete
Response to Neoadjuvant Cisplatin and Fluorouracil Chemotherapy in Resected Oral Cavity
Squamous Cell Carcinoma Federica Perrone, Paolo Bossi, Barbara Cortelazzi, Laura Locati,
Pasquale Quattrone, Marco A. Pierotti, Silvana Pilotti, and Lisa Licitra See accompanying
editorial on page 715 From the Unit of Experimental Molecu- lar Pathology, Department of …
Chemotherapy in Resected Oral Cavity S Page 1 TP53 Mutations and Pathologic Complete
Response to Neoadjuvant Cisplatin and Fluorouracil Chemotherapy in Resected Oral Cavity
Squamous Cell Carcinoma Federica Perrone, Paolo Bossi, Barbara Cortelazzi, Laura Locati,
Pasquale Quattrone, Marco A. Pierotti, Silvana Pilotti, and Lisa Licitra See accompanying
editorial on page 715 From the Unit of Experimental Molecu- lar Pathology, Department of …
Purpose
To find out if TP53 functional status predicts response to neoadjuvant chemotherapy and thus may be helpful during treatment decision making of oral cavity squamous cell carcinoma (SCC) patients.
academia.edu